204 related articles for article (PubMed ID: 28338194)
1. lncRNA NEAT1 is closely related with progression of breast cancer via promoting proliferation and EMT.
Zhang M; Wu WB; Wang ZW; Wang XH
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(5):1020-1026. PubMed ID: 28338194
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA NEAT1 is an unfavorable prognostic factor and regulates migration and invasion in gastric cancer.
Fu JW; Kong Y; Sun X
J Cancer Res Clin Oncol; 2016 Jul; 142(7):1571-9. PubMed ID: 27095450
[TBL] [Abstract][Full Text] [Related]
3. The long non-coding RNA NEAT1 interacted with miR-101 modulates breast cancer growth by targeting EZH2.
Qian K; Liu G; Tang Z; Hu Y; Fang Y; Chen Z; Xu X
Arch Biochem Biophys; 2017 Feb; 615():1-9. PubMed ID: 28034643
[TBL] [Abstract][Full Text] [Related]
4. LncRNA, NEAT1 is a prognosis biomarker and regulates cancer progression via epithelial-mesenchymal transition in clear cell renal cell carcinoma.
Ning L; Li Z; Wei D; Chen H; Yang C
Cancer Biomark; 2017; 19(1):75-83. PubMed ID: 28269753
[TBL] [Abstract][Full Text] [Related]
5. Long Non-Coding RNA NEAT1 Promotes the Proliferation, Migration, and Metastasis of Human Breast-Cancer Cells by Inhibiting miR-146b-5p Expression.
Li S; Hao J; Hong Y; Mai J; Huang W
Cancer Manag Res; 2020; 12():6091-6101. PubMed ID: 32801860
[TBL] [Abstract][Full Text] [Related]
6. The lncRNA NEAT1 facilitates cell growth and invasion via the miR-211/HMGA2 axis in breast cancer.
Li X; Wang S; Li Z; Long X; Guo Z; Zhang G; Zu J; Chen Y; Wen L
Int J Biol Macromol; 2017 Dec; 105(Pt 1):346-353. PubMed ID: 28720546
[TBL] [Abstract][Full Text] [Related]
7. Icariin Regulates EMT and Stem Cell-Like Character in Breast Cancer through Modulating lncRNA NEAT1/TGFβ/SMAD2 Signaling Pathway.
Song B; Wei F; Peng J; Wei X; Liu M; Nie Z; Ma Y; Peng T
Biol Pharm Bull; 2024 Feb; 47(2):399-410. PubMed ID: 38220208
[TBL] [Abstract][Full Text] [Related]
8. NEAT1 negatively regulates miR-218 expression and promotes breast cancer progression.
Zhao D; Zhang Y; Wang N; Yu N
Cancer Biomark; 2017 Sep; 20(3):247-254. PubMed ID: 28946559
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA NEAT1 overexpression is associated with unfavorable prognosis in patients with hepatocellular carcinoma after hepatectomy: A Chinese population-based study.
Liu Z; Chang Q; Yang F; Liu B; Yao HW; Bai ZG; Pu CS; Ma XM; Yang Y; Wang TT; Guo W; Zhou XN; Zhang ZT
Eur J Surg Oncol; 2017 Sep; 43(9):1697-1703. PubMed ID: 28732670
[TBL] [Abstract][Full Text] [Related]
10. Identification of lncRNA NEAT1/miR-21/RRM2 axis as a novel biomarker in breast cancer.
Quan D; Chen K; Zhang J; Guan Y; Yang D; Wu H; Wu S; Lv L
J Cell Physiol; 2020 Apr; 235(4):3372-3381. PubMed ID: 31621912
[TBL] [Abstract][Full Text] [Related]
11. Long non‑coding RNA nuclear paraspeckle assembly transcript 1 interacts with microRNA‑107 to modulate breast cancer growth and metastasis by targeting carnitine palmitoyltransferase‑1.
Xiong Y; Liu Z; Li Z; Wang S; Shen N; Xin Y; Huang T
Int J Oncol; 2019 Nov; 55(5):1125-1136. PubMed ID: 31485672
[TBL] [Abstract][Full Text] [Related]
12. NEAT1/miR‑124/STAT3 feedback loop promotes breast cancer progression.
Pang Y; Wu J; Li X; Wang C; Wang M; Liu J; Yang G
Int J Oncol; 2019 Sep; 55(3):745-754. PubMed ID: 31322202
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of LncRNA XIST and LncRNA NEAT1 for diagnosis of high-risk group breast cancer patients.
Swellam M; El Magdoub HM; Shawki MA; Adel M; Hefny MM; El-Shazly SS
Curr Probl Cancer; 2021 Oct; 45(5):100709. PubMed ID: 33602501
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of up-regulated lncRNA NEAT1 in prognosis of ovarian cancer.
Chen ZJ; Zhang Z; Xie BB; Zhang HY
Eur Rev Med Pharmacol Sci; 2016 Aug; 20(16):3373-7. PubMed ID: 27608895
[TBL] [Abstract][Full Text] [Related]
15. Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer.
Zhang K; Luo Z; Zhang Y; Zhang L; Wu L; Liu L; Yang J; Song X; Liu J
Cancer Biomark; 2016 Jun; 17(2):187-94. PubMed ID: 27540977
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA NEAT1 facilitates pancreatic cancer progression through negative modulation of miR-506-3p.
Huang B; Liu C; Wu Q; Zhang J; Min Q; Sheng T; Wang X; Zou Y
Biochem Biophys Res Commun; 2017 Jan; 482(4):828-834. PubMed ID: 27888106
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of long non-coding RNA CCAT1 is a novel biomarker of poor prognosis in patients with breast cancer.
Zhang XF; Liu T; Li Y; Li S
Int J Clin Exp Pathol; 2015; 8(8):9440-5. PubMed ID: 26464701
[TBL] [Abstract][Full Text] [Related]
18. Aberrant NEAT1 expression is associated with clinical outcome in high grade glioma patients.
He C; Jiang B; Ma J; Li Q
APMIS; 2016 Mar; 124(3):169-74. PubMed ID: 26582084
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of Long Non-Coding RNA UCA1 Increases the Tamoxifen Sensitivity of Breast Cancer Cells through Inhibition of Wnt/β-Catenin Pathway.
Liu H; Wang G; Yang L; Qu J; Yang Z; Zhou X
PLoS One; 2016; 11(12):e0168406. PubMed ID: 27977766
[TBL] [Abstract][Full Text] [Related]
20. LncRNA-ATB mediated E-cadherin repression promotes the progression of colon cancer and predicts poor prognosis.
Yue B; Qiu S; Zhao S; Liu C; Zhang D; Yu F; Peng Z; Yan D
J Gastroenterol Hepatol; 2016 Mar; 31(3):595-603. PubMed ID: 26487301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
